Imagine the possibility of accelerating your progress in small molecule drug discovery, despite the challenges posed by data constraints and unproductive leads. Don't miss this opportunity to witness how AI and high-quality data can transform your drug discovery journey. Join us in an exclusive webinar tomorrow as we explore the potential of reliable data, conquer data obstacles, design smarter, and tailor workflows to your needs. Register now! #lifesciences #pharma #biopharma #drugdevelopment #database #medicinalchemistry #gostar #aiddison #excelra Norman Azoulay Ashwini Ghogare, PhD Prasad Bidwe Nishanth Kandepedu PhD Bindu Ajithkumar Amar Thyagarajan, PhD Chandra Sekhar Pedamallu Jitendra Parekh Aparna Katoch Sapra, PhD. Radha Saradhi Reddy (Radha) Thammineni Anil Kumar M.
Excelra’s Post
More Relevant Posts
-
Want to know the secret to fast-tracking optimized #clinicalprogramming? Discover how Atorus transformed clinical programming for a global pharma leader with our strategic validation solutions. Our latest case study reveals the measurable impact of deploying over 200 validated R packages, enhancing efficiency, compliance, and overall performance. Fill out the form to access the full story and see how OpenVal® can revolutionize your clinical data processes. https://ow.ly/efBW50TeSEV #OpenVal #rstats #Clinicaldata
To view or add a comment, sign in
-
Struggling with data limitations and dead-end leads in your small molecule drug discovery pipeline? Join our exclusive live webinar and discover how the latest updates of AIDDISON software, newly enhanced with GOSTAR's robust databases, empower medicinal chemists to revolutionize their workflows.
Optimizing Data-Driven Drug Design with AIDDISON™ Software & GOSTAR®
event.on24.com
To view or add a comment, sign in
-
Struggling with data limitations and dead-end leads in your small molecule drug discovery pipeline? Join our exclusive live webinar and discover how the latest updates of AIDDISON software, newly enhanced with GOSTAR's robust databases, empower medicinal chemists to revolutionize their workflows. #ai #drugdiscovery
Optimizing Data-Driven Drug Design with AIDDISON™ Software & GOSTAR®
event.on24.com
To view or add a comment, sign in
-
PROMs are a valuable source of real-world data. They can help us to understand more about patient experiences with different treatment options and provide ongoing insight into the safety and efficacy of drugs. This paper explores the ways in which Sciensus is applying technology to collect ePROMs from the thousands of patients we support each year. To find out more, visit https://lnkd.in/evkhwrb3 #PROMs #CancerServices #realworlddata
To view or add a comment, sign in
-
Regulatory Affairs/Quality/Vigilance/Clinical/MedTech/Pharma/Medical Devices/IVDs/Combination/Foods/Cosmetics/Senior Leader/Lecturer/Global Regulations/PRRC/RP/QPPV/MDR/IVDR/FDA/MDSAP/ISO13485/GxP
Myself and my working party colleagues at TOPRA - The Organisation for Professionals in Regulatory Affairs are currently putting together our agenda for the Annual TOPRA Symposium 2024. We are currently reviewing abstracts received would love to hear your thoughts on the hottest topics/biggest concerns/challenges you would like to see discussed if attending a conference in 2024. Would love to see your comments below or PM me #topra #conference2024 #medtech #medicaldevices #ivd #mdr #ivdr #ai #healthcare #software #combinationproducts #pharma #humanmedicines
To view or add a comment, sign in
-
How can you ensure the quality and consistency of your cell cultures? Our Material Compliance Manager, Maximilian Gert-Kleint, has the answer. In an exclusive interview with RegMedNet, he explains the importance of using GMP grade media for cell-based research and therapies. He says, “Consistency is crucial for generating reliable and predictable results in research, development and manufacturing processes. GMP grade media help reduce variability in cell culture conditions, which can impact the reproducibility and comparability of experimental results.” If you want to learn more about how GMP grade media can enhance your cell culture performance and outcomes, click the link in the comments below. #GMP #cellculture
To view or add a comment, sign in
-
🧬 Scientifically Bold Monday - Edition 7 🧬 Sound familiar? We’ve all been there. Luckily, while the pressure may be real, our tools can handle the drug discovery part, streamlining the process and helping you meet those deadlines with confidence. Ready to reduce the pressure in your workflow? Learn more: https://lnkd.in/eqkT7bdr #BioSolveIT #DrugDiscovery #MedicinalChemistry
To view or add a comment, sign in
-
Rise of the Allotrope Simple Model: update from 2023 Fall Allotrope Connect Drug Discovery Today, an online magazine of ScienceDirect, published on March 2024 an article that presents the proceedings from the 2023 Fall Allotrope Connect conference and describes the technical and organizational developments in recent years. In particular, it describes the Allotrope Simple Model (ASM) that was developed to broaden the adoption. The article is available at https://lnkd.in/gXSfuVnG or PubMed at https://lnkd.in/gmJm9CYr
Rise of the Allotrope Simple Model: Update from 2023 Fall Allotrope Connect
sciencedirect.com
To view or add a comment, sign in
-
Navigating the world of Clinical Trial Management Systems (CTMS) can be overwhelming for small and mid-sized biotech companies. Our latest blog breaks down essential tips for choosing the perfect CTMS that fits your budget and growth needs! Key takeaways: - Prioritize cost-effectiveness and scalability - Look for user-friendly interfaces and seamless integration - Ensure robust compliance and support Don’t let trial management complexities hold you back. Discover how to select a CTMS that drives efficiency and success! #Biotech #ClinicalTrials #CTMS #LifeSciences #InnovationHow to Choose the Right CTMS for Small and Mid-Sized Biotech Companies https://bit.ly/3zd67vp
How to Choose the Right CTMS for Small and Mid-Sized Biotech Companies
To view or add a comment, sign in
-
Questions about Model Master Files (MMFs)? Similar to drug master files, MMFs can be referenced by multiple applications for a similar purpose of use, thus improving model sharing, model standardization, and regulatory consistency and efficiency. Join FDA and the Center for Research on Complex Generics for the “Considerations and Potential Regulatory Applications for a Model Master File” hybrid workshop on May 2-3, 2024. The workshop will discuss the concept, contexts of use, and operational aspects of MMFs, and illustrate how MMFs can make it easier the incorporate modeling and simulation during product development and to make regulatory assessment more efficient. Learn more & Register: https://lnkd.in/erCUuMm8
To view or add a comment, sign in
53,759 followers